Park Compounding Pharmacy Recalls Caffeine and Sodium Benzoate Vials
Park Compounding Pharmacy is recalling specific vials of Caffeine + Sodium Benzoate 500mg/mL due to a lack of assurance of sterility.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe severity score per the rubric for drug recalls with potential for temporary or medically reversible health consequences.
Plain-English summary
Chen Shwezin, Inc. dba Park Compounding Pharmacy is recalling 2 vials of Caffeine + Sodium Benzoate 500mg/mL, 35 mL vial, Rx only. The recall is due to a lack of assurance of sterility for all sterile compounded products within the expiry date.
The affected product is identified by Lot# 08062015@27 and has an expiration date of 11/4/15. The product was distributed in California (CA).
Consumers who have this specific product should contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- CAFFEINE + SODIUM BENZOATE 500MG/ML, 35 mL vial, Rx only, Park Compounding Pharmacy 280 N. Westlake Blvd., Ste. 100 Westlake Village, CA 91362, (805) 497-8258
- Manufacturer
- Chen Shwezin, Inc. dba Park Compounding Pharmacy
- Hazard
- Affected units
- 2
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot# 08062015@27
- Exp
- 11/4/15
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 5 recalled by Chen Shwezin, Inc. dba Park Compounding Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · Chen Shwezin, Inc. dba Park Compounding Pharmacy
See all →- SeverePark Compounding Pharmacy Recalls Methylcobalamin Vials Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SeverePark Compounding Pharmacy Recalls TRI-MIX Vials Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SeverePark Compounding Pharmacy Recalls Prostaglandin PGE-1 Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SeverePark Compounding Pharmacy Recalls TRI-MIX Vials Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
Same hazard · sterility failure
See all →- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereTransvenous Pacing Electrode Tray with Bipolar Balloon Pacing Electrode Recalled
FDA (Devices) · 2026-07-22
- SevereArterial Line Kit with Lidocaine HCL Injection Fails Sterility Testing
FDA (Devices) · 2026-07-22
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22